Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Cash from Financing Activities (2023 - 2025)

Corvus Pharmaceuticals has reported Cash from Financing Activities over the past 3 years, most recently at $20000.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $20000.0 for Q4 2025, down 99.89% from a year ago — trailing twelve months through Dec 2025 was $36.4 million (up 91.8% YoY), and the annual figure for FY2025 was $36.4 million, down 25.7%.
  • Cash from Financing Activities for Q4 2025 was $20000.0 at Corvus Pharmaceuticals, down from $360000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for CRVS hit a ceiling of $35.8 million in Q2 2025 and a floor of $4000.0 in Q1 2023.
  • Median Cash from Financing Activities over the past 3 years was $335000.0 (2023), compared with a mean of $7.0 million.
  • Peak annual rise in Cash from Financing Activities hit 620.0% in 2025, while the deepest fall reached 99.89% in 2025.
  • Corvus Pharmaceuticals' Cash from Financing Activities stood at $335000.0 in 2023, then surged by 5454.63% to $18.6 million in 2024, then crashed by 99.89% to $20000.0 in 2025.
  • The last three reported values for Cash from Financing Activities were $20000.0 (Q4 2025), $360000.0 (Q3 2025), and $35.8 million (Q2 2025) per Business Quant data.